|
|
||||||||
The Journal of Immunology, Vol 151, Issue 7 3672-3681, Copyright © 1993 by American Association of Immunologists
ARTICLES |
RT Gazzinelli, I Eltoum, TA Wynn and A Sher
Immunology and Cell Biology Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
C57BL/6 mice infected with the ME-49 strain of Toxoplasma gondii develop a progressive encephalitis culminating in 100% mortality between 12 and 15 wk after intraperitoneal inoculation of the parasite. Moreover, when injected at 4 wk after infection with anti-IFN-gamma mAb, progression of toxoplasmic encephalitis is markedly accelerated, resulting in death of the animals by 9 to 12 days posttreatment. In this study, we investigated the expression of mRNAs encoding cytokines as well as lymphocyte and macrophage markers during the development of toxoplasmic encephalitis. High levels of lymphocyte CD4 and CD8 surface Ag transcript were detected in the brains of mice throughout the infection. In addition from 2 to 4 wk we found elevations of Th1 (IFN- gamma and IL-2) but not of Th2 (IL-4 and IL-5) cytokine mRNAs. The elevation in Th1 cytokines was accompanied by increases in the expression of monokine (IL-1, IL-6, IL-10, granulocyte macrophage- colony stimulating factor [GM-CSF], and TNF-alpha) mRNAs, as well as markers expressed by activated macrophages (major histocompatibility class II [Ia], inducible nitric oxide synthase [iNOS] and macrophage activation gene 1 [Mag-1]). Interestingly, after 8 wk of infection with T. gondii we observed a dramatic decrease of Th1 cytokine and most monokine (IL-1, IL-6, GM-CSF, and TNF-alpha) as well as Mag-1 and iNOS mRNA levels. This down-regulation was associated with enhanced necrosis and neutrophilic infiltrates in the brain accompanied by increased expression of genes expressed specifically by the tachyzoite stage of T. gondii (T. gondii surface antigen 1 [SAG-1] and T. gondii surface antigen 2 [SAG-2]). Similarly, in mice chronically infected with T. gondii and treated with anti-IFN-gamma mAb the resulting pathology was associated with decreased expression of TNF-alpha and iNOS and increased expression of SAG-1 and SAG-2. Moreover, treatment with anti- TNF-alpha mAb also resulted in enhanced pathology, which correlated with low levels of iNOS mRNA and high levels of tachyzoite-specific mRNAs. Together these results suggest that reactivation of T. gondii results from a down-regulation of IFN-gamma and TNF-alpha expression leading to decreased macrophage or microglial cell activation, release of parasite growth, and subsequent tissue damage.
This article has been cited by other articles:
![]() |
J. P. Gigley, B. A. Fox, and D. J. Bzik Long-Term Immunity to Lethal Acute or Chronic Type II Toxoplasma gondii Infection Is Effectively Induced in Genetically Susceptible C57BL/6 Mice by Immunization with an Attenuated Type I Vaccine Strain Infect. Immun., December 1, 2009; 77(12): 5380 - 5388. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Ibrahim, H. Bannai, X. Xuan, and Y. Nishikawa Toxoplasma gondii Cyclophilin 18-Mediated Production of Nitric Oxide Induces Bradyzoite Conversion in a CCR5-Dependent Manner Infect. Immun., September 1, 2009; 77(9): 3686 - 3695. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Drogemuller, U. Helmuth, A. Brunn, M. Sakowicz-Burkiewicz, D. H. Gutmann, W. Mueller, M. Deckert, and D. Schluter Astrocyte gp130 Expression Is Critical for the Control of Toxoplasma Encephalitis J. Immunol., August 15, 2008; 181(4): 2683 - 2693. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Debierre-Grockiego, M. A. Campos, N. Azzouz, J. Schmidt, U. Bieker, M. G. Resende, D. S. Mansur, R. Weingart, R. R. Schmidt, D. T. Golenbock, et al. Activation of TLR2 and TLR4 by Glycosylphosphatidylinositols Derived from Toxoplasma gondii J. Immunol., July 15, 2007; 179(2): 1129 - 1137. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Thomas, A. Sapone, A. Fasano, and S. N. Vogel Gliadin Stimulation of Murine Macrophage Inflammatory Gene Expression and Intestinal Permeability Are MyD88-Dependent: Role of the Innate Immune Response in Celiac Disease J. Immunol., February 15, 2006; 176(4): 2512 - 2521. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Timoshanko, A. R. Kitching, T. J. Semple, S. R. Holdsworth, and P. G. Tipping Granulocyte Macrophage Colony-Stimulating Factor Expression by Both Renal Parenchymal and Immune Cells Mediates Murine Crescentic Glomerulonephritis J. Am. Soc. Nephrol., September 1, 2005; 16(9): 2646 - 2656. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, H. Kang, T. Kikuchi, and Y. Suzuki Gamma Interferon Production, but Not Perforin-Mediated Cytolytic Activity, of T Cells Is Required for Prevention of Toxoplasmic Encephalitis in BALB/c Mice Genetically Resistant to the Disease Infect. Immun., August 1, 2004; 72(8): 4432 - 4438. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Nguyen, G. Bigaignon, D. Markine-Goriaynoff, H. Heremans, T. N. Nguyen, G. Warnier, M. Delmee, M. Warny, S. F. Wolf, C. Uyttenhove, et al. Virulent Toxoplasma gondii strain RH promotes T-cell-independent overproduction of proinflammatory cytokines IL12 and {gamma}-interferon J. Med. Microbiol., October 1, 2003; 52(10): 869 - 876. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Araujo and T. Slifer Different Strains of Toxoplasma gondii Induce Different Cytokine Responses in CBA/Ca Mice Infect. Immun., July 1, 2003; 71(7): 4171 - 4174. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Schluter, L.-Y. Kwok, S. Lutjen, S. Soltek, S. Hoffmann, H. Korner, and M. Deckert Both Lymphotoxin-{alpha} and TNF Are Crucial for Control of Toxoplasma gondii in the Central Nervous System J. Immunol., June 15, 2003; 170(12): 6172 - 6182. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. King, D. S. Lindsay, S. Holladay, and M. Ehrich Neurotoxicity and Immunotoxicity Assessment in CBA/J Mice with Chronic Toxoplasma gondii Infection and Single-Dose Exposure to Methylmercury International Journal of Toxicology, January 1, 2003; 22(1): 53 - 61. [Abstract] [PDF] |
||||
![]() |
C. A. Dobbin, N. C. Smith, and A. M. Johnson Heat Shock Protein 70 Is a Potential Virulence Factor in Murine Toxoplasma Infection Via Immunomodulation of Host NF-{kappa}B and Nitric Oxide J. Immunol., July 15, 2002; 169(2): 958 - 965. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Benjamim, J. S. Silva, Z. B. Fortes, M. A. Oliveira, S. H. Ferreira, and F. Q. Cunha Inhibition of Leukocyte Rolling by Nitric Oxide during Sepsis Leads to Reduced Migration of Active Microbicidal Neutrophils Infect. Immun., July 1, 2002; 70(7): 3602 - 3610. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fujigaki, K. Saito, M. Takemura, N. Maekawa, Y. Yamada, H. Wada, and M. Seishima L-Tryptophan-L-Kynurenine Pathway Metabolism Accelerated by Toxoplasmagondii Infection Is Abolished in Gamma Interferon-Gene-Deficient Mice: Cross-Regulation between Inducible Nitric Oxide Synthase and Indoleamine-2,3-Dioxygenase Infect. Immun., February 1, 2002; 70(2): 779 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Silva, C. V. Rodrigues, M. M. Santoro, L. F. L. Reis, J. I. Alvarez-Leite, and R. T. Gazzinelli Expression of Indoleamine 2,3-Dioxygenase, Tryptophan Degradation, and Kynurenine Formation during In Vivo Infection with Toxoplasma gondii: Induction by Endogenous Gamma Interferon and Requirement of Interferon Regulatory Factor 1 Infect. Immun., February 1, 2002; 70(2): 859 - 868. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Schluter, M. Deckert, H. Hof, and K. Frei Toxoplasma gondii Infection of Neurons Induces Neuronal Cytokine and Chemokine Production, but Gamma Interferon- and Tumor Necrosis Factor-Stimulated Neurons Fail To Inhibit the Invasion and Growth of T. gondii Infect. Immun., December 1, 2001; 69(12): 7889 - 7893. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Feron, V. N. A. Klaren, E. A. Wierenga, G. M. G. M. Verjans, and A. Kijlstra Characterization of Toxoplasma gondii-Specific T Cells Recovered from Vitreous Fluid of Patients with Ocular Toxoplasmosis Invest. Ophthalmol. Vis. Sci., December 1, 2001; 42(13): 3228 - 3232. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Mordue, F. Monroy, M. La Regina, C. A. Dinarello, and L. D. Sibley Acute Toxoplasmosis Leads to Lethal Overproduction of Th1 Cytokines J. Immunol., October 15, 2001; 167(8): 4574 - 4584. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Halonen, G. A. Taylor, and L. M. Weiss Gamma Interferon-Induced Inhibition of Toxoplasma gondii in Astrocytes Is Mediated by IGTP Infect. Immun., September 1, 2001; 69(9): 5573 - 5576. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Shen, D. M. Matteson, N. Tuaillon, B. K. Suedekum, R. R. Buggage, and C.-C. Chan Involvement of Apoptosis and Interferon-{gamma} in Murine Toxoplasmosis Invest. Ophthalmol. Vis. Sci., August 1, 2001; 42(9): 2031 - 2036. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kang and Y. Suzuki Requirement of Non-T Cells That Produce Gamma Interferon for Prevention of Reactivation of Toxoplasma gondii Infection in the Brain Infect. Immun., May 1, 2001; 69(5): 2920 - 2927. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cai, R. Kastelein, and C. A. Hunter Interleukin-18 (IL-18) Enhances Innate IL-12-Mediated Resistance to Toxoplasma gondii Infect. Immun., December 1, 2000; 68(12): 6932 - 6938. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Black and J. C. Boothroyd Lytic Cycle of Toxoplasma gondii Microbiol. Mol. Biol. Rev., September 1, 2000; 64(3): 607 - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hesse, A. W. Cheever, D. Jankovic, and T. A. Wynn NOS-2 Mediates the Protective Anti-Inflammatory and Antifibrotic Effects of the Th1-Inducing Adjuvant, IL-12, in a Th2 Model of Granulomatous Disease Am. J. Pathol., September 1, 2000; 157(3): 945 - 955. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Halonen and L. M. Weiss Investigation into the Mechanism of Gamma Interferon-Mediated Inhibition of Toxoplasma gondii in Murine Astrocytes Infect. Immun., June 1, 2000; 68(6): 3426 - 3430. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Reichmann, W. Walker, E. N. Villegas, L. Craig, G. Cai, J. Alexander, and C. A. Hunter The CD40/CD40 Ligand Interaction Is Required for Resistance to Toxoplasmic Encephalitis Infect. Immun., March 1, 2000; 68(3): 1312 - 1318. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kang, J. S. Remington, and Y. Suzuki Decreased Resistance of B Cell-Deficient Mice to Infection with Toxoplasma gondii Despite Unimpaired Expression of IFN-{gamma}, TNF-{alpha}, and Inducible Nitric Oxide Synthase J. Immunol., March 1, 2000; 164(5): 2629 - 2634. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Khan and L. Casciotti IL-15 Prolongs the Duration of CD8+ T Cell-Mediated Immunity in Mice Infected with a Vaccine Strain of Toxoplasma gondii J. Immunol., October 15, 1999; 163(8): 4503 - 4509. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Marshall, L. R. Brunet, Y. van Gessel, A. Alcaraz, S. K. Bliss, E. J. Pearce, and E. Y. Denkers Toxoplasma gondii and Schistosoma mansoni Synergize to Promote Hepatocyte Dysfunction Associated with High Levels of Plasma TNF-{alpha} and Early Death in C57BL/6 Mice J. Immunol., August 15, 1999; 163(4): 2089 - 2097. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Tsutsui and T. Kamiyama Transforming Growth Factor beta -Induced Failure of Resistance to Infection with Blood-Stage Plasmodium chabaudi in Mice Infect. Immun., May 1, 1999; 67(5): 2306 - 2311. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Deckert-Schluter, H. Bluethmann, N. Kaefer, A. Rang, and D. Schluter Interferon-{gamma} Receptor-Mediated but Not Tumor Necrosis Factor Receptor Type 1- or Type 2-Mediated Signaling Is Crucial for the Activation of Cerebral Blood Vessel Endothelial Cells and Microglia in Murine Toxoplasma Encephalitis Am. J. Pathol., May 1, 1999; 154(5): 1549 - 1561. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Yap and A. Sher Effector Cells of Both Nonhemopoietic and Hemopoietic Origin Are Required for Interferon (IFN)-{gamma}- and Tumor Necrosis Factor (TNF)-{alpha}-dependent Host Resistance to the Intracellular Pathogen, Toxoplasma gondii J. Exp. Med., April 5, 1999; 189(7): 1083 - 1092. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Schluter, M. Deckert-Schluter, E. Lorenz, T. Meyer, M. Rollinghoff, and C. Bogdan Inhibition of Inducible Nitric Oxide Synthase Exacerbates Chronic Cerebral Toxoplasmosis in Toxoplasma gondii-Susceptible C57BL/6 Mice But Does Not Reactivate the Latent Disease in T. gondii-Resistant BALB/c Mice J. Immunol., March 15, 1999; 162(6): 3512 - 3518. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Perry, K. Feilzer, S. Hughes, and H. D. Caldwell Clearance of Chlamydia trachomatis from the Murine Genital Mucosa Does Not Require Perforin-Mediated Cytolysis or Fas-Mediated Apoptosis Infect. Immun., March 1, 1999; 67(3): 1379 - 1385. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Y. Denkers and R. T. Gazzinelli Regulation and Function of T-Cell-Mediated Immunity during Toxoplasma gondii Infection Clin. Microbiol. Rev., October 1, 1998; 11(4): 569 - 588. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Halonen, F.-C. Chiu, and L. M. Weiss Effect of Cytokines on Growth of Toxoplasma gondii in Murine Astrocytes Infect. Immun., October 1, 1998; 66(10): 4989 - 4993. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Salkowski, G. Detore, A. Franks, M. C. Falk, and S. N. Vogel Pulmonary and Hepatic Gene Expression following Cecal Ligation and Puncture: Monophosphoryl Lipid A Prophylaxis Attenuates Sepsis-Induced Cytokine and Chemokine Expression and Neutrophil Infiltration Infect. Immun., August 1, 1998; 66(8): 3569 - 3578. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Silva, R. T. Gazzinelli, D. A. O. Silva, E. A. V. Ferro, L. H. Kasper, and J. R. Mineo Expression of Toxoplasma gondii-Specific Heat Shock Protein 70 during In Vivo Conversion of Bradyzoites to Tachyzoites Infect. Immun., August 1, 1998; 66(8): 3959 - 3963. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Kim, Y. Tang, Y. Okada, T. A. Torrey, S. K. Chattopadhyay, M. Pfleiderer, F. G. Falkner, F. Dorner, W. Choi, N. Hirokawa, et al. Binding of Murine Leukemia Virus Gag Polyproteins to KIF4, a Microtubule-Based Motor Protein J. Virol., August 1, 1998; 72(8): 6898 - 6901. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Marshall and E. Y. Denkers Toxoplasma gondii Triggers Granulocyte-Dependent Cytokine-Mediated Lethal Shock in D-Galactosamine-Sensitized Mice Infect. Immun., April 1, 1998; 66(4): 1325 - 1333. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Johnson, A. M. Cooper, A. A. Frank, and I. M. Orme Adequate Expression of Protective Immunity in the Absence of Granuloma Formation in Mycobacterium tuberculosis-Infected Mice with a Disruption in the Intracellular Adhesion Molecule 1 Gene Infect. Immun., April 1, 1998; 66(4): 1666 - 1670. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Deckert-Schluter, H. Bluethmann, A. Rang, H. Hof, and D. Schluter Crucial Role of TNF Receptor Type 1 (p55), But Not of TNF Receptor Type 2 (p75), in Murine Toxoplasmosis J. Immunol., April 1, 1998; 160(7): 3427 - 3436. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sasaki, T. Miura, S. Nishikawa, K. Yamada, M. Hirasue, and A. Nakane Protective Role of Nitric Oxide in Staphylococcus aureus Infection in Mice Infect. Immun., March 1, 1998; 66(3): 1017 - 1022. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Yap, T. Scharton-Kersten, H. Charest, and A. Sher Decreased Resistance of TNF Receptor p55- and p75-Deficient Mice to Chronic Toxoplasmosis Despite Normal Activation of Inducible Nitric Oxide Synthase In Vivo J. Immunol., February 1, 1998; 160(3): 1340 - 1345. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Khan, J. D. Schwartzman, T. Matsuura, and L. H. Kasper A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice PNAS, December 9, 1997; 94(25): 13955 - 13960. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Giese, L. Gabriele, T. M. Doherty, D. M. Klinman, L. Tadesse-Heath, C. Contursi, S. L. Epstein, and H. C. Morse III Interferon (IFN) Consensus Sequence-binding Protein, a Transcription Factor of the IFN Regulatory Factor Family, Regulates Immune Responses In Vivo through Control of Interleukin 12 Expression J. Exp. Med., November 3, 1997; 186(9): 1535 - 1546. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Scharton-Kersten, G. Yap, J. Magram, and A. Sher Inducible Nitric Oxide Is Essential for Host Control of Persistent but Not Acute Infection with the Intracellular Pathogen Toxoplasma gondii J. Exp. Med., April 7, 1997; 185(7): 1261 - 1274. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |